Concepedia

Craig Wilson

CW

Statistics

Publications

20

Citations

4.4K

H-Index

17

Active since

1987

Affiliations

Takeda (United States)(Current)

University of Connecticut

University of Chicago

Harvard University

Cleveland Clinic

Craig Wilson is an author at Takeda (United States) specializing in medicine, diabetes mellitus, and cardiology.

Publications per year

1987–2024

20

Publications

20

Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

William B. White, Christopher P. Cannon, Simon Heller et al. · New England Journal of Medicine · 2013 · 2.5K citations · Full text

, , +14

Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial

Faı̈ez Zannad, Christopher P. Cannon, William C. Cushman et al. · The Lancet · 2015 · 754 citations · Full text

, , +17

Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Alogliptin in Patients With Type 2 Diabetes and Inadequate Glycemic Control

Ralph A. DeFronzo, P. Fleck, Craig Wilson et al. · Diabetes Care · 2008 · 224 citations · Full text

, , +17

EXamination of CArdiovascular OutcoMes with AlogliptIN versus Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome (EXAMINE)

William B. White, George L. Bakris, Richard M. Bergenstal et al. · American Heart Journal · 2011 · 152 citations

, , +17

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study

Richard E. Pratley, Jane E.B. Reusch, P. Fleck et al. · Current Medical Research and Opinion · 2009 · 132 citations

, , +17

1–5 of 20